A phase II randomized study of avelumab plus entinostat versus avelumab plus placebo in patients (pts) with advanced epithelial ovarian cancer (EOC) Meeting Abstract

  

Authors:	Cadoo, K. A.; Meyers, M. L.; Burger, R. A.; Armstrong, D. K.; Penson, R. T.; Gordon, M. S.; Fleming, G. F.; Moroney, J. W.; Hamilton, E. P.; Duska, L. R.; Wenham, R. M.; Sankoh, S.; Brouwer, S.; Ordentlich, P.; Aghajanian, C.; Matulonis, U. A.
Abstract Title:	A phase II randomized study of avelumab plus entinostat versus avelumab plus placebo in patients (pts) with advanced epithelial ovarian cancer (EOC)
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	316s
Language:	English
ACCESSION:	WOS:000487345805504
DOI:	10.1200/JCO.2019.37.15_suppl.5511
PROVIDER:	wos
Notes:	Meeting Abstract: 5511 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156236